Table 3 Pattern between economic indicators and site-standardized proxy relative survival (proxy SS-RS)
From: Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures
SS-RS | GNIpc | GDPpc | Total HEpc | Public HEpc |
(a) Recorded actual monetary values (US$) by proxy SS-RS [median (range)] | ||||
0.124 – <0.25 | 830 (260–13,760) | 903 (265–21,558) | 44 (15–853) | 16 (7–709) |
0.25 – <0.35 | 3500 (1040–19,560) | 3737 (955–22,135) | 183 (61–674) | 101 (18–478) |
0.35 – <0.45 | 8450 (2140–75,850) | 8558 (2047–88,565) | 551 (93–2049) | 320 (36–1726) |
0.45 – <0.55 | 34,480 (9210–61,650) | 32,570 (9985–58,508) | 2189 (931–6522) | 1392 (629–5501) |
0.55 – ≤0.622 | 46,710 (18,460–99,100) | 44,741 (19,730–106,749) | 4643 (1412–9361) | 3590 (942–7947) |
Targeted SS-RS | GNIpc | GDPpc | Total HEpc | Public HEpc |
(b) Projected monetary value (US$) [mean (95% confidence interval)] needed to reach a target proxy SS-RS | ||||
0.25 | 1524 (1322–1736) | 1567 (1350–1795) | 85 (74–97) | 38 (31–44) |
0.35 | 5238 (4713–5823) | 5447 (4880–6081) | 328 (295–365) | 178 (156–204) |
0.45 | 18,003 (15,774–20,810) | 18,930 (16,497–22,025) | 1260 (1104–1454) | 846 (716–1016) |
0.55 | 61,874 (50,963–77,034) | 65,792 (53,743–82,776) | 4840 (3989–6005) | 4013 (3141–5291) |